Episode Details

Back to Episodes
Predictmedix Preps for Big Year Ahead, as Demand for its Contactless Screening Devices sees Ramp Up of Partnerships, M&A and Strategic Financing

Predictmedix Preps for Big Year Ahead, as Demand for its Contactless Screening Devices sees Ramp Up of Partnerships, M&A and Strategic Financing

Season 3 Episode 71 Published 5 years, 7 months ago
Description

Predictmedix is an Artificial Intelligence company that has developed  fast, non-invasive, contactless screening devices that detect  infectious diseases, impairment and even mental illness at any location  where mass amounts of people gather, such as:

  • Hospitals
  • Stadiums
  • Airports
  • Malls
  • Government Buildings
  • Office Complexes

These screeners are fully automated and intelligent, so they don’t  need personnel to operate them. They determine the probability of a  person being infected with illnesses such as COVID-19, so safety  protocols can be initiated.

Earlier this month, the AI firm penned a major strategic partnership  with Juiceworks and Connectus Global to deploy its Safe Entry Stations  nationwide.

That news came during an increasingly busy time for $PMED, which has included:

  • An LOI to acquire AI-powered tech firm Symp2Pass
  • The engagement of investment banking firm Kingswood Capital Markets in preparation for NASDAQ listing
  • Major partnerships
  • Strategic financing developments

You’re going to want to get comfy for this chat with Predictmedix COO & Director Rahul Kushwah:

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us